Study limitation: Prevalence estimate (0.1%–1% of US population) is noted as uncertain by the authors due to historical underrecognition and lack of a diagnostic code prior to 2022 | ReachRx
Postural Orthostatic Tachycardia Syndrome (POTS)
Study limitation reported by the research below: “Prevalence estimate (0.1%–1% of US population) is noted as uncertain by the authors due to historical underrecognition and lack of a diagnostic code prior to 2022.”
